PHOP, as a research area, evaluates the cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational, and technological perspectives. Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research and translational research.The graduate program offers structured learning and experiences in health care systems, sociobehavioral sciences, health care quality, biostatistics, advanced regression analyses, research methods and design, pharmacoepidemiology, and pharmacoeconomics. Elective courses such as patient-reported outcomes and risk adjustment provide advanced learning experiences, along with the opportunities to participate in grant proposal writing as well as teaching and research practicums.
Study options
Full Time
(8 Semesters)
Tuition fees
US$17,118.00
per year
Student Services Fee - 260/sem
Start date
August 2027
Venue
Houston Campus
4226 Martin Luther King Boulevard,
Houston,
Texas,
77004, South, United States
Entry requirements
For international students
Applicants to the Pharmaceutical Health Outcomes and Policy PhD program must have either completed or expect to complete a BS degree in a similar area with an overall GPA of 3.0 on a 4-point scale. Applicants with a pharmacy background and/or advanced training will be given preference, and prospective students with health care-related backgrounds and/or experience are encouraged to apply. A GRE score is required to apply for the PhD program, and will be considered holistically with the students other credentials.
*There may be different IELTS requirements depending on your chosen course.